Hanlon P, Butterly E, Wei L, Wightman H, Almazam SA, Alsallumi K, et al
Stimulant-based medications Stimulant-based medications may not be appropriate for patients with uncontrolled blood pressure, certain heart rhythm issues, significant anxiety, or significant insomnia
In Eli Lillys clinical pharmacology data submitted to the FDA, a single 5 mg dose of tirzepatide reduced the maximum concentration of a birth control pill by roughly half and reduced overall exposure by about 20%
In addition to the possible health risks associated with the use of GLP-1 drugs, these therapies are associated with a high out-of-pocket cost for individuals who do not qualify for their use through insurance, such as those wanting to lose weight without falling into the obesity or diabetes categories
The Department of the Air Force has pledged to continue working with local communities and regulatory bodies to mitigate PFAS risks
Exercise recommendations for patients on semaglutide
